Antibodies to receptor activator of nuclear factor-κ B ligand (RANKL)

By Terpos Evangelos   Christoulas Dimitrios   Dimopoulos Meletios-Athanassios  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 11, 2008-11 ,pp. : 1265-1269

Informa Healthcare

Access to resources Recommend Favorite

Wortmannin Reduces Metastasis and Angiogenesis of Human Breast Cancer Cells via Nuclear Factor- B-dependent Matrix Metalloproteinase-9 and Interleukin-8 Pathways

By Li J   Li F   Wang H   Wang X   Jiang Y   Li D  

The Journal of International Medical Research, Vol. 40, Iss. 3, 2012-05 ,pp. : 867-876

Field House Publishing

Access to resources Recommend Favorite

Resveratrol inhibits NF-κB signaling through suppression of p65 and I B kinase activities

By Ren Zhenghua   Wang Lei   Cui Jianhua   Huoc Zeren   Xue Jinru   Cui Hao   Mao Qiqi   Yang Rirong  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 8, 2013-08 ,pp. : 689-694

Govi-Verlag

Access to resources Recommend Favorite

NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production

By Boire Gilles  

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 5, 2013-01 ,pp. : 353-361

NRC Research Press

Access to resources Recommend Favorite

Anti- and prooxidant effects of chronic quercetin administration in rats

By Choi E.J.   Chee K.-M.   Lee B.H.  

European Journal of Pharmacology, Vol. 482, Iss. 1, 2003-12 ,pp. : 281-285

Elsevier

Access to resources Recommend Favorite